Among the issues AdvaMed lobbied on were accountable care organizations, regulation of implantable devices, FDA approval and regulation of medical devices, and patents and trademarks.
AdvaMed reduced its spending by about 3 percent from the second quarter of 2010, when it spent about $379,000 on lobbying.
Related Articles on AdvaMed:
Key Business Groups Join Medical Device Industry in Opposing Tax
Study: Medical Device Spending Rising at Half the Rate of U.S. Inflation
Devicemakers Ask Congress to Ease Regulatory Burdens on Industry
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.